Authors: HERNES EH FOSSA SD VAAGE S OGREID P HEILO A PAUS E

Citation: Eh. Hernes et al., EPIRUBICIN COMBINED WITH ESTRAMUSTINE PHOSPHATE IN HORMONE-RESISTANT PROSTATE-CANCER - A PHASE-II STUDY, British Journal of Cancer, 76(1), 1997, pp. 93-99

Authors: MALMSTROM PU RINTALA E WAHLQVIST R HELLSTROM P HELLSTEN S HANNISDAL E ALFTHAN O RUSK J OPAS MA JAUHIAINEN K OTTELIN J PERMI J SALMELA H TAINIO H TALJA M TUHKANEN K VIITANEN J BREVIK B HOEG OM JOHANNESSEN NB FARSUND T MEDBY PC MURI O FOSSA SD OUS S SANDER S TVETER KJ OMLAND H STEINSVIK E URNES T WAALER G OGREID P OSTREM T ANDERSSON L EDSMYR F EKMAN P GUSTAFSON H NORMING U WIJKSTROM H KARLBERG L KIHL B LINDEBORG T

Citation: Pu. Malmstrom et al., 5-YEAR FOLLOW-UP OF A PROSPECTIVE TRIAL OF RADICAL CYSTECTOMY AND NEOADJUVANT CHEMOTHERAPY - NORDIC CYSTECTOMY TRIAL-I, The Journal of urology, 155(6), 1996, pp. 1903-1906

Authors: ABRAMS P SCHULMAN CC VAAGE S ABEL P BAXBY K BOEMINGHAUS F DELAERE KPJ DENIS L DIJKMAN GA HASSELLUND S HOHENFELLNER R JANKNEGT RA KAPPER BJ KARTHAUS HFM KHOE GSS KIL PJM KROMANNANDERSEN B LELIEFELD HHJ LOCK TMTW MOHR M MOMMSEN S OGREID P OTTO RW PLASMAN JWMH PULL HC RYTTOV N TOLLEY DA VENEMA PL WYNDAELE JJ YPMA AFGVM

Citation: P. Abrams et al., TAMSULOSIN, A SELECTIVE ALPHA(1C)-ADRENOCEPTOR ANTAGONIST - A RANDOMIZED, CONTROLLED TRIAL IN PATIENTS WITH BENIGN PROSTATIC OBSTRUCTION (SYMPTOMATIC BPH), British Journal of Urology, 76(3), 1995, pp. 325-336

Authors: FOSSA SD JACOBSEN AB AASS N HEILO A STENWIG AE KUMMEN O JOHANNESSEN NB WAALER G OGREID P BORGE L URNES T BJERKLUNDJOHANSEN T

Citation: Sd. Fossa et al., HOW SAFE IS SURVEILLANCE IN PATIENTS WITH HISTOLOGICALLY LOW-RISK NONSEMINOMATOUS TESTICULAR CANCER IN A GEOGRAPHICALLY EXTENDED COUNTRY WITH LIMITED COMPUTERIZED TOMOGRAPHIC RESOURCES, British Journal of Cancer, 70(6), 1994, pp. 1156-1160

Authors: WOEHRE H OUS S KLEVMARK B KVARSTEIN B URNES T OGREID P JOHANSEN TEB FOSSA SD

Citation: H. Woehre et al., A BLADDER-CANCER MULTIINSTITUTIONAL EXPERIENCE WITH TOTAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER-CANCER, Cancer, 72(10), 1993, pp. 3044-3051

Authors: FOSSA SD BERNER AA JACOBSEN AB WAEHRE H KVARSTEIN B URNES T OGREID P JOHANSEN TEB SILDE J NESLAND JM PETTERSEN EO

Citation: Sd. Fossa et al., CLINICAL-SIGNIFICANCE OF DNA-PLOIDY AND S-PHASE FRACTION AND THEIR RELATION TO P53 PROTEIN, C-ERBB-2 PROTEIN AND HCG IN OPERABLE MUSCLE-INVASIVE BLADDER-CANCER, British Journal of Cancer, 68(3), 1993, pp. 572-578